Table 4 Relation of triglyceride quartiles to progression to overall and cardiovascular mortality using multivariate Cox proportional hazards model.

From: There is a U shaped association between non high density lipoprotein cholesterol with overall and cardiovascular mortality in chronic kidney disease stage 3–5

Non-HDL cholesterol

Overall mortality

Cardiovascular mortality

Hazard ratio (95% CI)

p

Hazard ratio (95% CI)

p

Age and gender adjusted

 Quartile 1

1.612 (0.809–3.210)

0.175

2.717 (0.846–8.726)

0.093

 Quartile 2

Reference

Reference

 Quartile 3

1.880 (0.971–3.640)

0.061

2.432 (0.747–7.918)

0.140

 Quartile 4

1.480 (0.747–2.933)

0.262

2.319 (0.713–7.542)

0.162

Multivariate adjusted (1)

 Quartile 1

1.835 (0.911–3.696)

0.089

3.180 (0.966–10.470)

0.057

 Quartile 2

Reference

Reference

 Quartile 3

1.874 (0.950–3.697)

0.070

2.465 (0.736–8.263)

0.144

 Quartile 4

1.501 (0.741–3.039)

0.259

2.544 (0.758–8.538)

0.131

Multivariate adjusted (2)

 Quartile 1

2.081 (0.968–4.475)

0.061

5.545 (1.319–23.315)

0.019

 Quartile 2

Reference

Reference

 Quartile 3

2.392 (1.121–5.107)

0.024

5.453 (1.169–25.430)

0.031

 Quartile 4

1.599 (0.706–3.623)

0.261

3.840 (0.793–18.597)

0.095

  1. Values expressed as hazard ratio and 95% confidence interval (CI). Abbreviations are the same as in Table 1.
  2. Multivariate model 1: adjusted for age, gender, smoking, diabetes mellitus, hypertension, coronary artery disease and congestive heart failure, underlying disease of CKD and BMI.
  3. Multivariate model 2: adjusted for age, gender, smoking, diabetes mellitus, hypertension, coronary artery disease and congestive heart failure, underlying disease of CKD, BMI, systolic blood pressure ≧ 140 mmHg, fasting glucose, HbA1C, hemoglobin, eGFR < 30 ml/min/1.73 m2, total calcium, phosphorous, proteinuria, aspirin, ACEI and/or ARB, β-blocker, calcium channel blocker , diuretics and statin and/or fibrate use.
Back to article page